nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—Neurological impairment—Methotrexate—colon cancer	0.158	0.158	CcSEcCtD
Prilocaine—Arachnoiditis—Methotrexate—colon cancer	0.0299	0.0299	CcSEcCtD
Prilocaine—Neurotoxicity—Vincristine—colon cancer	0.0291	0.0291	CcSEcCtD
Prilocaine—Hypoaesthesia oral—Capecitabine—colon cancer	0.0281	0.0281	CcSEcCtD
Prilocaine—Hypoxemia—Methotrexate—colon cancer	0.0272	0.0272	CcSEcCtD
Prilocaine—Neurotoxicity—Capecitabine—colon cancer	0.0189	0.0189	CcSEcCtD
Prilocaine—Paralysis—Vincristine—colon cancer	0.0162	0.0162	CcSEcCtD
Prilocaine—Paraesthesia oral—Capecitabine—colon cancer	0.0157	0.0157	CcSEcCtD
Prilocaine—Neurotoxicity—Methotrexate—colon cancer	0.0141	0.0141	CcSEcCtD
Prilocaine—Numbness—Vincristine—colon cancer	0.0136	0.0136	CcSEcCtD
Prilocaine—Sensory loss—Vincristine—colon cancer	0.013	0.013	CcSEcCtD
Prilocaine—Extravasation—Vincristine—colon cancer	0.0129	0.0129	CcSEcCtD
Prilocaine—Numbness—Fluorouracil—colon cancer	0.0127	0.0127	CcSEcCtD
Prilocaine—Extravasation—Irinotecan—colon cancer	0.0126	0.0126	CcSEcCtD
Prilocaine—Sensory loss—Fluorouracil—colon cancer	0.0121	0.0121	CcSEcCtD
Prilocaine—Extravasation—Fluorouracil—colon cancer	0.012	0.012	CcSEcCtD
Prilocaine—Dysarthria—Irinotecan—colon cancer	0.0116	0.0116	CcSEcCtD
Prilocaine—Respiratory failure—Vincristine—colon cancer	0.0115	0.0115	CcSEcCtD
Prilocaine—Dysarthria—Fluorouracil—colon cancer	0.0111	0.0111	CcSEcCtD
Prilocaine—Neuropathy—Vincristine—colon cancer	0.0106	0.0106	CcSEcCtD
Prilocaine—Euphoric mood—Fluorouracil—colon cancer	0.00903	0.00903	CcSEcCtD
Prilocaine—Injury—Irinotecan—colon cancer	0.00867	0.00867	CcSEcCtD
Prilocaine—Swelling—Fluorouracil—colon cancer	0.00865	0.00865	CcSEcCtD
Prilocaine—Hypoxia—Methotrexate—colon cancer	0.00861	0.00861	CcSEcCtD
Prilocaine—Disorientation—Fluorouracil—colon cancer	0.00853	0.00853	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Irinotecan—colon cancer	0.00823	0.00823	CcSEcCtD
Prilocaine—Osteoarthritis—Irinotecan—colon cancer	0.00797	0.00797	CcSEcCtD
Prilocaine—Paralysis—Methotrexate—colon cancer	0.00787	0.00787	CcSEcCtD
Prilocaine—Cardiac failure—Fluorouracil—colon cancer	0.00782	0.00782	CcSEcCtD
Prilocaine—Cardiac arrest—Vincristine—colon cancer	0.00778	0.00778	CcSEcCtD
Prilocaine—Dysarthria—Capecitabine—colon cancer	0.00776	0.00776	CcSEcCtD
Prilocaine—Cyanosis—Methotrexate—colon cancer	0.00772	0.00772	CcSEcCtD
Prilocaine—Osteoarthritis—Fluorouracil—colon cancer	0.00763	0.00763	CcSEcCtD
Prilocaine—Cardiac arrest—Irinotecan—colon cancer	0.00757	0.00757	CcSEcCtD
Prilocaine—Cardiac arrest—Fluorouracil—colon cancer	0.00725	0.00725	CcSEcCtD
Prilocaine—Depressed level of consciousness—Capecitabine—colon cancer	0.00709	0.00709	CcSEcCtD
Prilocaine—Neuropathy—Capecitabine—colon cancer	0.0069	0.0069	CcSEcCtD
Prilocaine—Extravasation—Methotrexate—colon cancer	0.00627	0.00627	CcSEcCtD
Prilocaine—Neuropathy peripheral—Vincristine—colon cancer	0.00618	0.00618	CcSEcCtD
Prilocaine—Swelling—Capecitabine—colon cancer	0.00604	0.00604	CcSEcCtD
Prilocaine—Sweating—Vincristine—colon cancer	0.00604	0.00604	CcSEcCtD
Prilocaine—Sweating—Irinotecan—colon cancer	0.00588	0.00588	CcSEcCtD
Prilocaine—Dysarthria—Methotrexate—colon cancer	0.00578	0.00578	CcSEcCtD
Prilocaine—Neuropathy peripheral—Fluorouracil—colon cancer	0.00576	0.00576	CcSEcCtD
Prilocaine—Hypoaesthesia—Vincristine—colon cancer	0.00563	0.00563	CcSEcCtD
Prilocaine—Bradycardia—Irinotecan—colon cancer	0.00561	0.00561	CcSEcCtD
Prilocaine—Respiratory failure—Methotrexate—colon cancer	0.00557	0.00557	CcSEcCtD
Prilocaine—Cardiac failure—Capecitabine—colon cancer	0.00546	0.00546	CcSEcCtD
Prilocaine—Diplopia—Capecitabine—colon cancer	0.00533	0.00533	CcSEcCtD
Prilocaine—Osteoarthritis—Capecitabine—colon cancer	0.00533	0.00533	CcSEcCtD
Prilocaine—Depressed level of consciousness—Methotrexate—colon cancer	0.00528	0.00528	CcSEcCtD
Prilocaine—Hypoaesthesia—Fluorouracil—colon cancer	0.00525	0.00525	CcSEcCtD
Prilocaine—Cardiac arrest—Capecitabine—colon cancer	0.00507	0.00507	CcSEcCtD
Prilocaine—Arrhythmia—Irinotecan—colon cancer	0.00492	0.00492	CcSEcCtD
Prilocaine—Arrhythmia—Fluorouracil—colon cancer	0.00471	0.00471	CcSEcCtD
Prilocaine—Anaemia—Vincristine—colon cancer	0.00455	0.00455	CcSEcCtD
Prilocaine—Bronchospasm—Capecitabine—colon cancer	0.00453	0.00453	CcSEcCtD
Prilocaine—Anaemia—Irinotecan—colon cancer	0.00443	0.00443	CcSEcCtD
Prilocaine—Vision blurred—Fluorouracil—colon cancer	0.00433	0.00433	CcSEcCtD
Prilocaine—Syncope—Irinotecan—colon cancer	0.0043	0.0043	CcSEcCtD
Prilocaine—Hypertension—Vincristine—colon cancer	0.00425	0.00425	CcSEcCtD
Prilocaine—Anaemia—Fluorouracil—colon cancer	0.00425	0.00425	CcSEcCtD
Prilocaine—Loss of consciousness—Irinotecan—colon cancer	0.00422	0.00422	CcSEcCtD
Prilocaine—Hypertension—Irinotecan—colon cancer	0.00414	0.00414	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Methotrexate—colon cancer	0.0041	0.0041	CcSEcCtD
Prilocaine—Neuropathy peripheral—Capecitabine—colon cancer	0.00403	0.00403	CcSEcCtD
Prilocaine—Anaphylactic shock—Vincristine—colon cancer	0.00402	0.00402	CcSEcCtD
Prilocaine—Oedema—Vincristine—colon cancer	0.00402	0.00402	CcSEcCtD
Prilocaine—Osteoarthritis—Methotrexate—colon cancer	0.00397	0.00397	CcSEcCtD
Prilocaine—Confusional state—Irinotecan—colon cancer	0.00395	0.00395	CcSEcCtD
Prilocaine—Nervous system disorder—Vincristine—colon cancer	0.00394	0.00394	CcSEcCtD
Prilocaine—Oedema—Irinotecan—colon cancer	0.00391	0.00391	CcSEcCtD
Prilocaine—Anaphylactic shock—Irinotecan—colon cancer	0.00391	0.00391	CcSEcCtD
Prilocaine—Hyperhidrosis—Vincristine—colon cancer	0.00389	0.00389	CcSEcCtD
Prilocaine—Shock—Irinotecan—colon cancer	0.00385	0.00385	CcSEcCtD
Prilocaine—Nervous system disorder—Irinotecan—colon cancer	0.00384	0.00384	CcSEcCtD
Prilocaine—Hyperhidrosis—Irinotecan—colon cancer	0.00378	0.00378	CcSEcCtD
Prilocaine—Confusional state—Fluorouracil—colon cancer	0.00378	0.00378	CcSEcCtD
Prilocaine—Hypotension—Vincristine—colon cancer	0.00376	0.00376	CcSEcCtD
Prilocaine—Bradycardia—Capecitabine—colon cancer	0.00375	0.00375	CcSEcCtD
Prilocaine—Oedema—Fluorouracil—colon cancer	0.00375	0.00375	CcSEcCtD
Prilocaine—Anaphylactic shock—Fluorouracil—colon cancer	0.00375	0.00375	CcSEcCtD
Prilocaine—Nervous system disorder—Fluorouracil—colon cancer	0.00368	0.00368	CcSEcCtD
Prilocaine—Hypoaesthesia—Capecitabine—colon cancer	0.00367	0.00367	CcSEcCtD
Prilocaine—Hypotension—Irinotecan—colon cancer	0.00366	0.00366	CcSEcCtD
Prilocaine—Paraesthesia—Vincristine—colon cancer	0.00361	0.00361	CcSEcCtD
Prilocaine—Paraesthesia—Irinotecan—colon cancer	0.00352	0.00352	CcSEcCtD
Prilocaine—Hypotension—Fluorouracil—colon cancer	0.0035	0.0035	CcSEcCtD
Prilocaine—Somnolence—Irinotecan—colon cancer	0.00348	0.00348	CcSEcCtD
Prilocaine—Tinnitus—Capecitabine—colon cancer	0.00344	0.00344	CcSEcCtD
Prilocaine—Pain—Vincristine—colon cancer	0.00344	0.00344	CcSEcCtD
Prilocaine—Paraesthesia—Fluorouracil—colon cancer	0.00337	0.00337	CcSEcCtD
Prilocaine—Pain—Irinotecan—colon cancer	0.00335	0.00335	CcSEcCtD
Prilocaine—Somnolence—Fluorouracil—colon cancer	0.00333	0.00333	CcSEcCtD
Prilocaine—Arrhythmia—Capecitabine—colon cancer	0.00329	0.00329	CcSEcCtD
Prilocaine—Feeling abnormal—Irinotecan—colon cancer	0.00323	0.00323	CcSEcCtD
Prilocaine—Pain—Fluorouracil—colon cancer	0.00321	0.00321	CcSEcCtD
Prilocaine—Feeling abnormal—Fluorouracil—colon cancer	0.00309	0.00309	CcSEcCtD
Prilocaine—Drowsiness—Methotrexate—colon cancer	0.00306	0.00306	CcSEcCtD
Prilocaine—Vision blurred—Capecitabine—colon cancer	0.00303	0.00303	CcSEcCtD
Prilocaine—Tremor—Capecitabine—colon cancer	0.00301	0.00301	CcSEcCtD
Prilocaine—Urticaria—Fluorouracil—colon cancer	0.00298	0.00298	CcSEcCtD
Prilocaine—Anaemia—Capecitabine—colon cancer	0.00297	0.00297	CcSEcCtD
Prilocaine—Hypersensitivity—Vincristine—colon cancer	0.00296	0.00296	CcSEcCtD
Prilocaine—Sweating—Methotrexate—colon cancer	0.00293	0.00293	CcSEcCtD
Prilocaine—Hypersensitivity—Irinotecan—colon cancer	0.00288	0.00288	CcSEcCtD
Prilocaine—Asthenia—Vincristine—colon cancer	0.00288	0.00288	CcSEcCtD
Prilocaine—Syncope—Capecitabine—colon cancer	0.00288	0.00288	CcSEcCtD
Prilocaine—Loss of consciousness—Capecitabine—colon cancer	0.00282	0.00282	CcSEcCtD
Prilocaine—Asthenia—Irinotecan—colon cancer	0.00281	0.00281	CcSEcCtD
Prilocaine—Hypertension—Capecitabine—colon cancer	0.00277	0.00277	CcSEcCtD
Prilocaine—Hypersensitivity—Fluorouracil—colon cancer	0.00276	0.00276	CcSEcCtD
Prilocaine—Anxiety—Capecitabine—colon cancer	0.00272	0.00272	CcSEcCtD
Prilocaine—Dizziness—Vincristine—colon cancer	0.00266	0.00266	CcSEcCtD
Prilocaine—Confusional state—Capecitabine—colon cancer	0.00264	0.00264	CcSEcCtD
Prilocaine—Oedema—Capecitabine—colon cancer	0.00262	0.00262	CcSEcCtD
Prilocaine—Dizziness—Irinotecan—colon cancer	0.00259	0.00259	CcSEcCtD
Prilocaine—Shock—Capecitabine—colon cancer	0.00258	0.00258	CcSEcCtD
Prilocaine—Nervous system disorder—Capecitabine—colon cancer	0.00257	0.00257	CcSEcCtD
Prilocaine—Tinnitus—Methotrexate—colon cancer	0.00256	0.00256	CcSEcCtD
Prilocaine—Vomiting—Vincristine—colon cancer	0.00256	0.00256	CcSEcCtD
Prilocaine—Hyperhidrosis—Capecitabine—colon cancer	0.00253	0.00253	CcSEcCtD
Prilocaine—Vomiting—Irinotecan—colon cancer	0.00249	0.00249	CcSEcCtD
Prilocaine—Dizziness—Fluorouracil—colon cancer	0.00248	0.00248	CcSEcCtD
Prilocaine—Hypotension—Capecitabine—colon cancer	0.00245	0.00245	CcSEcCtD
Prilocaine—Nausea—Vincristine—colon cancer	0.00239	0.00239	CcSEcCtD
Prilocaine—Vomiting—Fluorouracil—colon cancer	0.00238	0.00238	CcSEcCtD
Prilocaine—Paraesthesia—Capecitabine—colon cancer	0.00235	0.00235	CcSEcCtD
Prilocaine—Nausea—Irinotecan—colon cancer	0.00233	0.00233	CcSEcCtD
Prilocaine—Vision blurred—Methotrexate—colon cancer	0.00225	0.00225	CcSEcCtD
Prilocaine—Pain—Capecitabine—colon cancer	0.00224	0.00224	CcSEcCtD
Prilocaine—Nausea—Fluorouracil—colon cancer	0.00223	0.00223	CcSEcCtD
Prilocaine—Anaemia—Methotrexate—colon cancer	0.00221	0.00221	CcSEcCtD
Prilocaine—Feeling abnormal—Capecitabine—colon cancer	0.00216	0.00216	CcSEcCtD
Prilocaine—Urticaria—Capecitabine—colon cancer	0.00208	0.00208	CcSEcCtD
Prilocaine—Confusional state—Methotrexate—colon cancer	0.00197	0.00197	CcSEcCtD
Prilocaine—Anaphylactic shock—Methotrexate—colon cancer	0.00195	0.00195	CcSEcCtD
Prilocaine—Hypersensitivity—Capecitabine—colon cancer	0.00193	0.00193	CcSEcCtD
Prilocaine—Nervous system disorder—Methotrexate—colon cancer	0.00191	0.00191	CcSEcCtD
Prilocaine—Hyperhidrosis—Methotrexate—colon cancer	0.00189	0.00189	CcSEcCtD
Prilocaine—Asthenia—Capecitabine—colon cancer	0.00188	0.00188	CcSEcCtD
Prilocaine—Hypotension—Methotrexate—colon cancer	0.00182	0.00182	CcSEcCtD
Prilocaine—Paraesthesia—Methotrexate—colon cancer	0.00175	0.00175	CcSEcCtD
Prilocaine—Somnolence—Methotrexate—colon cancer	0.00173	0.00173	CcSEcCtD
Prilocaine—Dizziness—Capecitabine—colon cancer	0.00173	0.00173	CcSEcCtD
Prilocaine—Pain—Methotrexate—colon cancer	0.00167	0.00167	CcSEcCtD
Prilocaine—Vomiting—Capecitabine—colon cancer	0.00167	0.00167	CcSEcCtD
Prilocaine—Feeling abnormal—Methotrexate—colon cancer	0.00161	0.00161	CcSEcCtD
Prilocaine—Nausea—Capecitabine—colon cancer	0.00156	0.00156	CcSEcCtD
Prilocaine—Urticaria—Methotrexate—colon cancer	0.00155	0.00155	CcSEcCtD
Prilocaine—Hypersensitivity—Methotrexate—colon cancer	0.00144	0.00144	CcSEcCtD
Prilocaine—Asthenia—Methotrexate—colon cancer	0.0014	0.0014	CcSEcCtD
Prilocaine—Dizziness—Methotrexate—colon cancer	0.00129	0.00129	CcSEcCtD
Prilocaine—Vomiting—Methotrexate—colon cancer	0.00124	0.00124	CcSEcCtD
Prilocaine—Nausea—Methotrexate—colon cancer	0.00116	0.00116	CcSEcCtD
